CDKN2A and neoplasm: In CM, it has been proposed that subsequent mutations occur in the TERT promoter and in regulators of the cell cycle such as CDKN2A, which precede mutations in chromatin remodelers such as members of the SWI/SNF complex and TP53, the latter being associated with more advanced stages of primary tumour progression 5.